In contrast, Quercetin-3-O-glucoside and Celecoxib acted as bFGF inhibitors, avoiding the expansion of local metastasis induced by various growth factors in pancreatic cancers and promoting their use as an effective adjuvant to boost chemotherapeutic agents [119,120]. The gene discussed is FGF2; the disease is pancreatic neoplasm.